4.7 Article

Cholesterol 25-hydroxylase inhibits encephalomyocarditis virus replication through enzyme activity-dependent and independent mechanisms

Journal

VETERINARY MICROBIOLOGY
Volume 245, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.vetmic.2020.108658

Keywords

Antiviral; Cholesterol25-hydroxylase (CH25H); 25-hydroxycholesterol (25HC); Encephalomyocarditis virus (EMCV); 3D protein

Funding

  1. China Agricultural Research System Foundation [CARS-36]
  2. National Natural Science Foundation [31502082]
  3. State Key Laboratory of Veterinary Etiological Biology
  4. Jiangsu Province (PAPD)

Ask authors/readers for more resources

Cholesterol-25-hydroxylase (CH25 H) is a reticulum-associated membrane protein induced by an important interferon-stimulating gene (ISG) and can significantly inhibit some virus replication. But the effect of CH25H on encephalomyocarditis virus (EMCV) is still not clear. In this study, we found that EMCV infection increases significantly the endogenous CH25H expression in BHK-21 and N2a cells. CH25H and cholesterol catalytic oxidation product 25-hydroxycholesterol (25HC) obviously inhibits EMCV infection by inhibiting the viral penetration. But the CH25H mutant lacking hydroxylase activity repairs the ability to inhibit the viral replication. Meanwhile, beta-cyclodextrin crystalline as a cholesterol inhibitor significantly decreases the viral replication. In addition, CH25H can selectively interact and degrade the viral RNA-Dependent RNA Polymerase-3D protein by independent on the association of proteasome, lysosome and caspase manner. It provides new insights into the interplay mechanisms between CH25H and non-enveloped single-stranded positive RNA viruses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available